全文获取类型
收费全文 | 925篇 |
免费 | 43篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 43篇 |
妇产科学 | 32篇 |
基础医学 | 68篇 |
口腔科学 | 55篇 |
临床医学 | 90篇 |
内科学 | 372篇 |
皮肤病学 | 14篇 |
神经病学 | 14篇 |
特种医学 | 137篇 |
外科学 | 34篇 |
综合类 | 12篇 |
预防医学 | 31篇 |
眼科学 | 18篇 |
药学 | 29篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 17篇 |
出版年
2022年 | 3篇 |
2021年 | 5篇 |
2020年 | 4篇 |
2019年 | 5篇 |
2018年 | 12篇 |
2017年 | 20篇 |
2016年 | 18篇 |
2015年 | 11篇 |
2014年 | 15篇 |
2013年 | 31篇 |
2012年 | 36篇 |
2011年 | 37篇 |
2010年 | 34篇 |
2009年 | 32篇 |
2008年 | 32篇 |
2007年 | 35篇 |
2006年 | 46篇 |
2005年 | 25篇 |
2004年 | 17篇 |
2003年 | 33篇 |
2002年 | 19篇 |
2001年 | 20篇 |
2000年 | 16篇 |
1999年 | 20篇 |
1998年 | 29篇 |
1997年 | 31篇 |
1996年 | 45篇 |
1995年 | 41篇 |
1994年 | 34篇 |
1993年 | 22篇 |
1992年 | 9篇 |
1991年 | 14篇 |
1990年 | 10篇 |
1989年 | 27篇 |
1988年 | 26篇 |
1987年 | 25篇 |
1986年 | 21篇 |
1985年 | 22篇 |
1984年 | 12篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 12篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 5篇 |
1973年 | 2篇 |
1965年 | 2篇 |
排序方式: 共有977条查询结果,搜索用时 15 毫秒
181.
Objective
To evaluate the therapeutic effects of the embedding needle therapy in the preventative treatment of chronic migraine.Methods
A total of 36 patients with chronic migraine were divided into an embedding needle therapy group and a flunarizine group according to random number table, 18 cases in each group. In the embedding needle therapy group, the thumb-tack needles were used at Sīzhúkōng (丝竹空TE 23), Hànyàn (颔厌GB 4), Wáng? (完骨GB 12) and Cuánzhú (攒竹BL 2) and the needles were embedded for 24 h. The embedding needle therapy was given three times a week. In the flunarizine group, flunarizine was prescribed, 10 mg a day. Separately, at the end of the 4-week treatment and in 4 weeks of the follow-up, the number of days of headache attack per month (days/month) and the headache duration (hours/month) in the cases with moderate to severe headache were observed in the two groups.Results
The number of days of headache attack in the cases with moderate to severe headache was reduced after treatment as compared with the number before treatment in the two groups. The headache duration was reduced obviously after treatment in the cases of moderate to severe headache in the two groups. In the 4-week follow-up, all the indexes were still reduced as compared with the indexes before treatment, indicating the significant differences in the two groups (both P < 0.05). In the embedding needle therapy group, at the end of the 4-week treatment and in 4 weeks of the follow-up, the number of days of headache attack per month was (8.1 ± 2.4) days and (7.2 ± 1.6) days separately, which were significant difference as compared with (9.7 ± 2.3) days and (8.9 ± 1.4) days in the flunarizine group (both P < 0.05). Regarding the headache duration, at the end of the 4-week treatment and in 4 weeks of the follow-up, it was (105.6 ± 10.5) h/month and (92.1 ± 7.2) h/month respectively in the embedding needle therapy group, indicating the significant differences as compared with (135.4 ± 8.9) h and (116.1 ± 8.2) h in the flunarizine group respectively (both P < 0.05).Conclusion
The 4-week treatment with the embedding needle therapy obviously reduces the number of days of headache attack and the headache duration, presents the preventative effects in the patients with chronic migraine. 相似文献182.
183.
Plasma serotonin in autism 总被引:1,自引:0,他引:1
Connors SL Matteson KJ Sega GA Lozzio CB Carroll RC Zimmerman AW 《Pediatric neurology》2006,35(3):182-186
Serotonin is necessary for normal fetal brain development. Administration of serotonin inhibitors to pregnant rats results in offspring with abnormal behaviors, brain morphology, and serotonin receptor numbers. Low maternal plasma serotonin may contribute to abnormal brain development in autism. In this study, plasma serotonin levels in autism mothers and control mothers of typically developing children were compared, and plasma serotonin levels in children with autism (n = 17) and their family members were measured. Plasma serotonin levels in autism mothers were significantly lower than in mothers of normal children (P = 0.002). Plasma serotonin levels correlated between autism mothers and their children, but differed between autistic children and their fathers (P = 0.028) and siblings (P = 0.063). Low maternal plasma serotonin may be a risk factor for autism through effects on fetal brain development. 相似文献
184.
Marleen?J?NahuisEmail author Nienke?S?Weiss Fulco?van der Veen Ben?Willem?J?Mol Peter?G?Hompes Jur?Oosterhuis Nils?B?Lambalk Jesper?MJ?Smeenk Carolien?AM?Koks Ron?JT?van Golde Joop?SE?Laven Ben?J?Cohlen Kathrin?Fleischer Angelique?J?Goverde Marie?H?Gerards Nicole?F?Klijn Lizka?CM?Nekrui Ilse?AJ?van Rooij Diederik?A?Hoozemans Madelon?van Wely 《BMC women's health》2013,13(1):42
Background
Clomiphene citrate (CC) is first line treatment in women with World Health Organization (WHO) type II anovulation and polycystic ovary syndrome (PCOS). Whereas 60% to 85% of these women will ovulate on CC, only about one half will have conceived after six cycles. If women do not conceive, treatment can be continued with gonadotropins or intra-uterine insemination (IUI). At present, it is unclear for how many cycles ovulation induction with CC should be repeated, and when to switch to ovulation induction with gonadotropins and/or IUI.Methods/Design
We started a multicenter randomised controlled trial in the Netherlands comparing six cycles of CC plus intercourse or six cycles of gonadotrophins plus intercourse or six cycles of CC plus IUI or six cycles of gonadotrophins plus IUI.Women with WHO type II anovulation who ovulate but did not conceive after six ovulatory cycles of CC with a maximum of 150 mg daily for five days will be included.Our primary outcome is birth of a healthy child resulting from a pregnancy that was established in the first eight months after randomisation. Secondary outcomes are clinical pregnancy, miscarriage, multiple pregnancy and treatment costs. The analysis will be performed according to the intention to treat principle. Two comparisons will be made, one in which CC is compared to gonadotrophins and one in which the addition of IUI is compared to ovulation induction only. Assuming a live birth rate of 40% after CC, 55% after addition of IUI and 55% after ovulation induction with gonadotrophins, with an alpha of 5% and a power of 80%, we need to recruit 200 women per arm (800 women in total).An independent Data and Safety Monitoring Committee has criticized the data of the first 150 women and concluded that a sample size re-estimation should be performed after including 320 patients (i.e. 80 per arm).Discussion
The trial will provide evidence on the most effective, safest and most cost effective treatment in women with WHO type II anovulation who do not conceive after six ovulatory cycles with CC with a maximum of 150 mg daily for five days. This evidence could imply the need for changing our guidelines, which may cause a shift in large practice variation to evidence based primary treatment for these women.Trial registration number
Netherlands Trial register NTR1449185.
Akkara Veetil Bharath Manu Matteson Eric L Maradit-Kremers Hilal McEvoy Marian T Crowson Cynthia S 《BMC dermatology》2012,12(1):1-6
Melasma is an acquired increased pigmentation of the skin characterized by symmetrical and confluent grey-brown patches usually on the areas of the face exposed to the sun. Silymarin strongly prevents photocarcinogenesis, and significantly prevented melanin production. The objectives of this study were the assessment of safety and efficacy of topical Silymain (SM) cream in a double-blind placebo controlled study for treatment of melasma patients. Experimentally on 24 Albino rabbits were randomly divided into 4 equal groups. [A] No treatment, [B] received placebo, [C] treated with SM cream (0.1), &; [D] treated by SM (0.2), were applied topically before UV sun light exposure for 30 days, assessed clinically &; tissue pathology. Clinically on 96 adults diagnosed with melasma randomized to three equal groups to receive one of the tested drugs applied twice daily for 4 weeks, evaluated by the response; lesion size, melasma area and severity index score, Physician global assessment, and subjective assessment. The Clinical and histopathology observations were reduced significantly in SM groups. Clinically; all patients showed significant excellent pigment improvement &; lesion size reduction with SM treatments from the 1st week. All patients were fully satisfied 100%. No side effects were observed. Silymarin showed tremendous improvement of melasma in a dose-dependent manner, and was effective in prevention of skin damage caused by U.V. sunlight. It is a safe new candidate effective treatment for melasma. Australian New Zealand Clinical Trials Registry - ACTRN12612000602820 相似文献
186.
187.
188.
189.
Predicting serious bacterial infection in young children with fever without apparent source 总被引:1,自引:0,他引:1
SE Bleeker KGM Moons G Derksen-Lubsen DE Grobbee HA Moll 《Acta paediatrica (Oslo, Norway : 1992)》2001,90(11):1226-1231
The aim of this study was to design a clinical rule to predict the presence of a serious bacterial infection in children with fever without apparent source. Information was collected from the records of children aged 1-36 mo who attended the paediatric emergency department because of fever without source (temperature > or = 38 degrees C and no apparent source found after evaluation by a general practitioner or history by a paediatrician). Serious bacterial infection included bacterial meningitis, sepsis, bacteraemia, pneumonia, urinary tract infection, bacterial gastroenteritis, osteomyelitis and ethmoiditis. Using multivariate logistic regression and the area under the receiver operating characteristic curve (ROC area), the diagnostic value of predictors for serious bacterial infection was judged, resulting in a risk stratification. Twenty-five percent of the 231 patients enrolled in the study (mean age 1.1 y) had a serious bacterial infection. Independent predictors from history and examination included duration of fever, poor micturition, vomiting, age, temperature < 36.7 degrees C or > or = 40 degrees C at examination, chest-wall retractions and poor peripheral circulation (ROC area: 0.75). Independent predictors from laboratory tests were white blood cell count, serum C-reactive protein and the presence of >70 white blood cells in urinalysis (ROC area: 0.83). The risk stratification for serious bacterial infection ranged from 6% to 92%. CONCLUSION: The probability of a serious bacterial infection in the individual patient with fever without source can be estimated more precisely by using a limited number of symptoms, signs and laboratory tests. 相似文献
190.
The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors 总被引:18,自引:1,他引:18
The monoclonal antibody STRO-1 identifies clonogenic bone marrow stromal cell progenitors (fibroblast colony-forming units [CFU-F]) in adult human bone marrow. These STRO-1+ CFU-F have previously been shown to give rise to cells with the phenotype of fibroblasts, adipocytes, and smooth muscle cells. In this study, the osteogenic potential of CFU- F derived from the STRO-1+ fraction of adult human bone marrow was determined. CFU-F were isolated from normal bone marrow aspirates by fluorescence activated cell sorting, based on their expression of the STRO-1 antigen. Osteogenic differentiation was assessed by the induction of alkaline phosphatase expression, by the formation of a mineralized matrix (hydroxyapatite), and by the production of the bone- specific protein osteocalcin. STRO-1+ cells were cultured in the presence of dexamethasone (DEX; 10(-8) mol/L), ascorbic acid 2- phosphate (ASC-2P; 100 mumol/L), and inorganic phosphate (PO4i; 2.9 mmol/L). After 2 weeks of culture, greater than 90% of the cells in each CFU-F colony stained positive for alkaline phosphatase using a monoclonal antibody specific for bone and liver alkaline phosphatase. Alkaline phosphatase activity was confirmed by histochemistry. A mineralized matrix developed in the CFU-F cultures, after 4 weeks of culture in the presence of DEX, ASC-2P, and PO4i. Mineralization was confirmed by both light and electron microscopy. The mineral was identified as hydroxyapatite by electron dispersive x-ray microanalysis and by x-ray diffraction analysis. In replicate cultures, osteocalcin release was shown after exposure of the cells to 1,25-dihydroxyvitamin D3 (10(-7) mol/L) both by radioimmunoassay and Northern blot analysis. This work provides direct evidence that adult human bone marrow-derived CFU-F are capable of differentiating into functional osteoblasts and that osteoprogenitors are present in the STRO-1+ population. 相似文献